StockData
Tevogen Inc. logo

Tevogen Inc. (TVGN) stock

TVGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGNW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$6.22+0.22 (+3.67%)

Close on Nov 16, 2026Market cap $40.50MP/E –Yield –

Tevogen EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Tevogen

Tevogen has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Tevogen figures

See a number that looks wrong?